Phenotype associated env gene variation among 8 related HIV-1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Phenotype associated env gene variation among 8 related HIV-1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.

Int Conf AIDS. 1992 Jul 19-24;8(1):Mo20 (abstract no. MoA 0075). Unique Identifier : AIDSLINE ICA8/92400031
Groenink M; Andeweg AC; van der Jagt RC; Schuitemaker H; Bosch ML; Huisman JG; Tersmette M; Centr. Lab. Netherlands Red Cross Blood Transf. Serv., Amsterdam.


Abstract: OBJECTIVES: To genetically compare phenotypically heterogeneous HIV-1 variants and to analyze regions of the HIV-1 env gene previously identified as determinants of biological properties. METHODS: Eight phenotypically heterogeneous HIV-1 clones, recovered directly from a single patient peripheral blood mononuclear cells under limiting dilution conditions, were compared for the nucleotide sequences of their env genes. In addition, the accessory gene sequences were obtained for four of these clones. RESULTS: Four clones with intermediate phenotypes were the product of genetic recombination events. In contrast to the accessory genes, all 8 HIV-1 clones demonstrated extensive phenotype-associated sequence variation dispersed non-randomly over the env gene. Sequence variation associated with syncytium inducing (SI) capacity and tropism for the MT2 T-cell line was concentrated in the C1-V4 region of the gp120 glycoprotein. In contrast, sequence variation associated with tropism for the H9 and Sup T1 T-cell lines was completely limited to the gp120-V5 region and the gp41 glycoprotein. The fusion domain, and amino acids involved in gp120-CD4 and gp120-gp41 interaction and their directly surrounding residues were completely conserved. The SI clones, which differed in their tropism for primary monocytes and T-cell lines possessed identical V3 sequences. CONCLUSION: Three clones most likely resulted from genetic recombination events in vivo, indicating that this phenomenon may account for the emergence of proviruses with novel phenotypic properties during the course of the HIV-1 infection. Variation among most accessory genes was limited. The finding of identical V3 sequences in clones differing in tropism for primary monocytes and T-cell lines demonstrated the existence of determinants of tropism outside the env V3 region, most probably located within the gp120-V5 region and the gp41 molecule.
Keywords: Antigenic Variation/GENETICS Cells, Cultured *Genes, env Human HIV Envelope Protein gp120/*GENETICS/PHYSIOLOGY HIV Envelope Protein gp41/*GENETICS/PHYSIOLOGY HIV Infections/MICROBIOLOGY HIV-1/*GENETICS/ISOLATION & PURIF/PHYSIOLOGY Leukocytes, Mononuclear/MICROBIOLOGY Phenotype Recombination, Genetic T-Lymphocytes/MICROBIOLOGY ABSTRACTKWDantigenicvariation/geneticscells,culturedKWDgenes,envhumanhivenvelopeproteingp120/KWDgenetics/physiologyhivenvelopeproteingp41/KWDgenetics/physiologyhivinfections/microbiologyhiv-1/KWDgenetics/isolation&purif/physiologyleukocytes,mononuclear/microbiologyphenotyperecombination,genetict-lymphocytes/microbiologyabstract
921230
M92C5316

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .